Search

3i Group PLC

Fermé

SecteurIndices

3,341 -0.92

Résumé

Variation du prix de l'action

24h

Actuel

Min

3232

Max

3388

Chiffres clés

By Trading Economics

Revenu

3B

Ventes

1.6B

P/E

Moyenne du Secteur

8.273

18.062

BPA

3.09

Rendement du dividende

1.74

Marge bénéficiaire

188.169

Employés

223

EBITDA

3B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+40.08% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.74%

8.03%

Date du Prochain Dividende

9 janv. 2026

Date du Prochain Détachement de Dividende

27 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.7B

44B

Ouverture précédente

3341.92

Clôture précédente

3341

3i Group PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 nov. 2025, 10:02 UTC

Résultats
Principaux Mouvements du Marché

3i Group Shares Tumble After Cautious Outlook

13 nov. 2025, 07:29 UTC

Résultats

3i Group: First Div Is Set at 50% of Total Div for FY2025

13 nov. 2025, 07:29 UTC

Résultats

3i Group PLC Declares Dividend of 36.5p

13 nov. 2025, 07:28 UTC

Résultats

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 nov. 2025, 07:28 UTC

Résultats

3i Group Ended Period With Liquidity of GBP1.64B

13 nov. 2025, 07:26 UTC

Résultats

3i Group: Several of Other Large Portfolio Companies Are Showing Good Momentum

13 nov. 2025, 07:25 UTC

Résultats

3i Group: Action Continued to Trade Strongly

13 nov. 2025, 07:25 UTC

Résultats

3i Group Private Equity Business Delivered a Gross Investment Return of GBP3.23B

13 nov. 2025, 07:25 UTC

Résultats

3i Group Total Return GBP3.29B, or 13% on Opening Shareholders' Funds

13 nov. 2025, 07:12 UTC

Résultats

3i Group: Action Generated Net Sales of EUR11.23B in Nine Reporting Periods Ending Sep. 28

13 nov. 2025, 07:07 UTC

Résultats

3i Group Private Equity Business Gross Investment Return GBP3.23B

13 nov. 2025, 07:07 UTC

Résultats

3i Group Had Liquidity of GBP1.64B at Sep. 30

13 nov. 2025, 07:07 UTC

Résultats

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 nov. 2025, 07:05 UTC

Résultats

3i Group Raises Dividend to 36.5p Vs 30.5p

13 nov. 2025, 07:03 UTC

Résultats

3i Group: Transaction Market and Wider Environment Likely to Remain Challenging Into Fiscal 2H

13 nov. 2025, 07:03 UTC

Résultats

3i Group: Remain Cautious in Deployment of Capital Into New Investment, Will Continue to Allocate Selectively

13 nov. 2025, 07:02 UTC

Résultats

3i Group 1H NAV/Shr 2,857p

13 nov. 2025, 07:02 UTC

Résultats

3i Group Total Return GBP3.29B

13 nov. 2025, 07:00 UTC

Résultats

3i 1H EPS GBP3.398

13 nov. 2025, 07:00 UTC

Résultats

3i 1H NAV/Shr GBP28.57

2 sept. 2025, 11:16 UTC

Market Talk

3i Group Seems to Value Investments Conservatively -- Market Talk

2 sept. 2025, 06:40 UTC

Acquisitions, Fusions, Rachats

3i Group: Price is 30% Premium to MAIT's March 31 Valuation

2 sept. 2025, 06:39 UTC

Acquisitions, Fusions, Rachats

3i Group Selling MAIT for GBP143M

2 sept. 2025, 06:38 UTC

Acquisitions, Fusions, Rachats

3i Group: DBAG is a Private Equity Fund Advised by Deutsche Beteiligungs

2 sept. 2025, 06:38 UTC

Acquisitions, Fusions, Rachats

3i Group: MAIT is IT Services Provider for Mid-Market Customers in DACH Region

2 sept. 2025, 06:38 UTC

Acquisitions, Fusions, Rachats

3i Group to Sell MAIT to DBAG

24 juil. 2025, 06:09 UTC

Résultats

3i Group: Focus on Actively Managing Portfolio, Remain Cautious on Pricing for New Investment

24 juil. 2025, 06:09 UTC

Résultats

3i Group: Resilient Performance from Majority of Remaining Private Equity Portfolio

24 juil. 2025, 06:09 UTC

Résultats

3i Group 1Q Foreign Exchange Translation Gain GBP392M

24 juil. 2025, 06:04 UTC

Résultats

3i Group YTD Operating EBITDA GBP980M

3i Group PLC prévision

Objectif de Prix

By TipRanks

40.08% hausse

Prévisions sur 12 Mois

Moyen 4,706.67 GBX  40.08%

Haut 5,200 GBX

Bas 4,100 GBX

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

7 ratings

5

Achat

2

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat